Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеВсе още не набира
Спонсори
Zhong Wang

Ключови думи

Резюме

The study aims to assess the antibacterial effect and symptoms-relief of Qingfei Granule in the patients with pediatric acute upper respiratory tract infection with bacterial infection.

Описание

Upper respiratory tract infection is the most common respiratory disease in childhood, and the incidence rate accounts for more than 60% of pediatric outpatients, ranking first in pediatric diseases. At present, antibiotics are commonly used to treat children with upper respiratory tract infections. However, due to the large amount of clinical use of antibiotics in recent years, the resistance of various pathogens has become stronger and stronger, which has caused the majority of clinicians and researchers to turn their attention to traditional Chinese medicine. Qingfei Granule is composed of six common herbal medicines such as Schizonepeta (Jing-Jie),Radix Scutellariae (Huang-qin),Forsythia (Lian-Qiao), etc. After upper respiratory tract infections with bacterial infections, chills, fever, runny nose, red and sore throat may occur, and may be accompanied by mild cough, thin red tongue, yellow moss, floating pulse,which is considered as the exogenous wind-heat Zheng in Chinese medicine. The study aims to assess the antibacterial effect and symptoms-relief of Qingfei Granule in the patients with pediatric acute upper respiratory tract infection with bacterial infection.

Дати

Последна проверка: 06/30/2020
Първо изпратено: 07/16/2020
Очаквано записване подадено: 07/16/2020
Първо публикувано: 07/20/2020
Изпратена последна актуализация: 07/19/2020
Последна актуализация публикувана: 07/21/2020
Действителна начална дата на проучването: 07/31/2020
Приблизителна дата на първично завършване: 07/31/2021
Очаквана дата на завършване на проучването: 09/30/2021

Състояние или заболяване

Upper Respiratory Tract Infection
Bacterial Infection
Chinese Medicine
Pediatric Acute Upper Respiratory Tract Infection

Интервенция / лечение

Drug: QingFei Granule+Cefuroxime group

Drug: Cefuroxime

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Experimental: QingFei Granule+Cefuroxime group
Cefuroxime:30mg/kg/d,bid QingFei Granule: tid
Drug: QingFei Granule+Cefuroxime group
QingFei Granule is made from 6 commonly herbal medicine granule, such as Jingjie,Huang Qin,Lianqiao,etc. The children were given one package of QingFei Granule every day, dividing into 3 times to be administrated. It's be given for 5 days.
Active Comparator: Cefuroxime group
Cefuroxime:30mg/kg/d,bid

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 5 Years Да се 5 Years
Полове, допустими за проучванеAll
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

1. Diagnosis with the acute upper respiratory tract infection;

2. Diagnosis with wind-heat Zheng according to Chinese medicine;

3. Age: 5-14 years old;

4. Body temperature ≥ 37.5 ℃;

5. White blood cell count> 12 × 10^9 / L, and / or neutrophil ratio over than 70%;

6. The informed consent process complies with the regulations, and the legal agent or the child (≥8 years old) jointly sign the informed consent

Exclusion Criteria:

(1) Acute bacterial otitis media; (2) Patients with periodontitis or periodontal abscess (3) Candidiasis; (4) Patients with positive mycoplasma; (5) Taking antibiotics, anti-inflammatory drugs, and antihistamines; (6) Patients with severe comorbidities of heart, liver and kidney; (7) Other patients with acute infectious diseases and mycoplasma pneumoniae infections with symptoms similar to upper respiratory tract infection; (8) Children with a history of epilepsy or convulsions; (9) Patients with mental illness; (10) Those who are allergic to treatment drugs; (11) Participated in other clinical trials in the past month; (12) The investigator evaluates that it is not suitable to participate in this clinical trial or according to the investigator's judgment, who is likely to loss to follow-up.

-

Резултат

Първични изходни мерки

1. Bacterial clearance [0, Day 5]

The pharyngeal swabs were used for sampling, and the pharyngeal flora diversity amplicon sequencing was used to analyze the pharyngeal flora spectrum, and the change of pathogenic bacteria flora spectrum before and after treatment was analyzed to qualitatively judge the bacterial clearance. Calculate the bacterial clearance rate = (number of people removed / total number of people tested) × 100%

Вторични изходни мерки

1. Clinical remission rate of disease [Day 3,Day 5]

The clinical remission rate of disease is defined as: the main symptoms such as chills, fever, nasal congestion, runny nose, sore throat, cough, etc. alleviate or disappear. Upper respiratory tract infection symptom scale score decreased by more than 70% compared with baseline

2. Fever clearance time [Up to Day 5]

record once every 4 to 8 h after treatment.

3. Treatment failure rate [Up to Day 5]

Treatment failure is defined as: body temperature does not decrease for 3 consecutive days, and / or complicated by laryngitis, tracheobronchitis, pneumonia, myocarditis, and / or oral antibiotics are switched to intravenous antibiotics.

4. The incidence of the complications [Up to Day 5]

complicated with laryngitis, tracheo-bronchitis, pneumonia, myocarditis and other complications

5. The usage of the ibuprofen [Up to Day 5]

If the temperature is over 38.5℃ or the child feel unbearable discomfort, the child will be given with ibuprofen. The usage of the ibuprofen (including the usage times and detail amount will be recorded in the patients' dairy.

6. The usage of antibiotics (Cefuroxime) [Up to Day 5]

The usage of Cefuroxime (including the usage times and detail amount will be recorded in the patients' dairy.

7. The normalization rate of the blood routine [Day 3, Day 5]

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge